Castellano   Català    English        

Castellano   Català    English        

Castellano   Català    English        

Noticias

Actualizado: 11/06/2014 ver todas >

Grupo Uriach leads the way in the treatment of allergies in adults and children

Approximately 7500 specialists from across the world met in Copenhagen, Denmark at EAACI 2014, the world’s leading medical congress on allergy and immunology, to discuss recent... [leer más]  


Uriach consolidates its international expansion by licensing Rupatadine on the Japanese market

Japan is the world’s largest market for antihistamines; sales  are higher than in Europe. Rupatadine, one of Uriach’s star products, will be launched on the Japanese market in the next four... [leer más]  


Uriach strategic transformation is beginning to show results

Uriach Group EBITDA grew by 100% compared to the previous year, going from 10 to 20 million euros. This was achieved by aligning the activity of its four strategic business areas: OTC and Natural Care, Generics, Pharma Licensing and Contract Manufacturing.

[leer más]  


Contactar

Avinguda Cami Reial, 51-57
08184 Palau-Solita, Plegamans
(Barcelona) España
ver en google maps
Telf: 902 471 511
Web: www.uriach.com

 

Contact us

Avinguda Cami Reial, 51-57
08184 Palau-Solita, Plegamans
(Barcelona) España
on google maps
Phone: 0034 902 471 511
Web: www.uriach.com

 

Contactar

Avinguda Cami Reial, 51-57
08184 Palau-Solita, Plegamans
(Barcelona) España
veure a google maps
Telf: 902 471 511
Web: www.uriach.com